Price
No data yet.
Social Signal Score
Revenue
$28.47M+1233.18%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Roderick de Greef
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Employees
- 155
- Beta
- 1.90
- Country
- US
- Piotroski score
- 5 / 9 (Middling)
- Altman Z-score
- 38.48
Financials
Revenue
$28.47M+1233.2%Net Income
$45.10MEBITDA
$2.91MFree Cash Flow
$6.51MEPS (diluted)
$0.91Shares Outstanding (diluted)
49.29M+288.2%Operating Expenses
$16.43MCash & Debt
$82.42MReturn of Capital
$0.00Revenue by Segment (annual)
$82.25MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $96.21M | $-12.13M | $-0.25 |
| 2024 | $82.25M | $-20.18M | $-0.44 |
| 2023 | $68.02M | $-68.00M | $-1.55 |
| 2022 | $76.24M | $-139.81M | $-3.29 |
| 2021 | $119.16M | $-8.91M | $-0.22 |
| 2020 | $48.09M | $2.67M | $-0.03 |
| 2019 | $27.37M | $-1.66M | $-0.09 |
| 2018 | $19.74M | $-25.00M | $-1.56 |
| 2017 | $11.02M | $-2.52M | $-0.21 |
| 2016 | $8.23M | $-6.88M | $-0.54 |
| 2015 | $6.45M | $-4.21M | $-0.35 |
| 2014 | $6.19M | $-3.22M | $-0.31 |
| 2013 | $8.95M | $-1.08M | $-0.22 |
| 2012 | $5.66M | $-1.66M | $-0.33 |
Valuation
BLFShas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
100Social Signal Score
Mentions (1)
- Newsbusinesswire.com·6h ago·Neutral
BLFS Stock Alert: Halper Sadeh LLC is Investigating Whether BioLife Solutions, Inc. is Obtaining a Fair Price for its Shareholders NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of BioLife Solutions, Inc. (NASDAQ: BLFS) to Repligen Corporation for $11.25 per share in cash and 0.1442 shares of Repligen common stock.Halper Sadeh encourages BioLife shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or …
View source ↗
Earnings
Thu, Nov 5(in 2 months)
Consensus estimate $0.01 per share
Typical surprise +266.7% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Aug 6$0.91 vs $0.03beat
- Thu, May 7$0.04 vs $0.01beat
- Thu, Feb 26$0.04 vs $-0.02beat
- Thu, Nov 6$0.04 vs $0.00beat
- Thu, Aug 7$-0.33 vs $-0.02miss
- Thu, May 8$0.04 vs $-0.03beat
Estimates and results for BLFS via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by BLFS officers and directors.
- Bought
- —
- Sold
- $56.7m
0 trades
53 trades
- Casdin Partners Master Fund, L.p.sold
- Casdin Partners Master Fund, L.p.sold
- Casdin Partners Master Fund, L.p.sold
- Foster Karen A.sold
- Foster Karen A.sold
- Foster Karen A.sold
- Werner Seansold
- Foster Karen A.sold
47 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.